Brain Cancer Clinical Trials

Showing 461-480 of 693 trials

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

NCT02431572

This research study is studying the changes in primary and metastatic brain tumor inflammation using positron emission tomography (PET) imaging using a radioactive substance called \[11C\] PBR28a, which is also known as peripheral benzodiazepine receptors (PBR), or PBR-PET.

Intracranial TumorsGlioblastomaMelanoma

Massachusetts General Hospital11 participantsStarted May 2015

Boston, Massachusetts, United States • Boston, Massachusetts, United States

COMPLETED

CTCs for High Grade Glioma

NCT02558335

The purpose of this study is to identify and quantify circulating tumor markers, which are associated with the presence of tumors. The current imaging available does not allow specificity of tumor size as it relates to pseudoprogression (a temporary enlargement or "swelling" of the tumor after treatment before it shrinks). Our hope is that CTCs will provide a more accurate description of tumor state for high grade glioma patients.

Stage III and IV Glioma Patients

Abramson Cancer Center at Penn Medicine30 participantsStarted Apr 2013

Philadelphia, Pennsylvania, United States

COMPLETEDPHASE1/PHASE2

Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme

NCT01260506

The purpose of this study is to evaluate the safety, tolerability and efficacy of VB-111 in patients with Relapsed Glioblastoma Multiforme.

Glioblastoma Multiforme

Vascular Biogenics Ltd. operating as VBL Therapeutics75 participantsStarted Dec 2010

Boston, Massachusetts, United States • Durham, North Carolina, United States • San Antonio, Texas, United States +1 more locations

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

CTCs for High Grade Glioma

Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme

Related Searches

Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas

Dovitinib in Neuroendocrine Tumors

Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study

Nivolumab With DC Vaccines for Recurrent Brain Tumors

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors

A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma

Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas

First in Patient Study for PF-06840003 in Malignant Gliomas

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133

Natural History of Patients With Brain and Spinal Cord Tumors

Biomarker-based Algorithm for Diagnosis of Glioma

Genetic Analysis of Brain Tumors

A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors

Molecular Heterogeneity in Multilobar Low-grade Gliomas